XY Labs, Inc. (XYLB)

XY Labs, Inc. (XYLB) — VMCI valuation read

Across 120 indicators, XY Labs, Inc. (XYLB) lands at VMCI 24/100. The Technology sector median is 50, so the 26-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on XYLB in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, XYLB trades at 25.0x earnings, 39% above the Technology median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Technology median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 0.5x leaves covenant headroom for XYLB on the trailing balance sheet.

XYLB rose 0.2% over the trailing 7 days, with a -12.6% read on a 30-day basis.